These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
306 related items for PubMed ID: 15511602
1. Reproductive events modify the effects of estrogen replacement therapy on cognition in healthy postmenopausal women. Dunkin J, Rasgon N, Wagner-Steh K, David S, Altshuler L, Rapkin A. Psychoneuroendocrinology; 2005 Apr; 30(3):284-96. PubMed ID: 15511602 [Abstract] [Full Text] [Related]
2. Estrogen therapy selectively enhances prefrontal cognitive processes: a randomized, double-blind, placebo-controlled study with functional magnetic resonance imaging in perimenopausal and recently postmenopausal women. Joffe H, Hall JE, Gruber S, Sarmiento IA, Cohen LS, Yurgelun-Todd D, Martin KA. Menopause; 2006 Apr; 13(3):411-22. PubMed ID: 16735938 [Abstract] [Full Text] [Related]
3. Effects of ultra-low-dose transdermal estradiol on cognition and health-related quality of life. Yaffe K, Vittinghoff E, Ensrud KE, Johnson KC, Diem S, Hanes V, Grady D. Arch Neurol; 2006 Jul; 63(7):945-50. PubMed ID: 16831962 [Abstract] [Full Text] [Related]
4. Testosterone aromatization and cognition in women: a randomized, placebo-controlled trial. Shah S, Bell RJ, Savage G, Goldstat R, Papalia MA, Kulkarni J, Donath S, Davis SR. Menopause; 2006 Jul; 13(4):600-8. PubMed ID: 16837882 [Abstract] [Full Text] [Related]
5. A 20-week randomized controlled trial of estradiol replacement therapy for women aged 70 years and older: effect on mood, cognition and quality of life. Almeida OP, Lautenschlager NT, Vasikaran S, Leedman P, Gelavis A, Flicker L. Neurobiol Aging; 2006 Jan; 27(1):141-9. PubMed ID: 16298249 [Abstract] [Full Text] [Related]
6. Hormone replacement therapy and cognitive function in postmenopausal women. Kurt M, Bekçi B, Karakaş S. Maturitas; 2006 Jan 10; 53(1):39-48. PubMed ID: 16325023 [Abstract] [Full Text] [Related]
7. Effects of ultralow-dose transdermal estradiol on postmenopausal symptoms in women aged 60 to 80 years. Diem S, Grady D, Quan J, Vittinghoff E, Wallace R, Hanes V, Ensrud K. Menopause; 2006 Jan 10; 13(1):130-8. PubMed ID: 16607109 [Abstract] [Full Text] [Related]
8. No differences in performance on test of working memory and executive functioning between healthy elderly postmenopausal women using or not using hormone therapy. Grigorova M, Sherwin BB. Climacteric; 2006 Jun 10; 9(3):181-94. PubMed ID: 16766432 [Abstract] [Full Text] [Related]
9. The effect of 3-year treatment with 0.25 mg/day of micronized 17beta-estradiol on cognitive function in older postmenopausal women. Pefanco MA, Kenny AM, Kaplan RF, Kuchel G, Walsh S, Kleppinger A, Prestwood K. J Am Geriatr Soc; 2007 Mar 10; 55(3):426-31. PubMed ID: 17341247 [Abstract] [Full Text] [Related]
10. Limited cognitive benefits in Stage +2 postmenopausal women after 6 weeks of treatment with Ginkgo biloba. Elsabagh S, Hartley DE, File SE. J Psychopharmacol; 2005 Mar 10; 19(2):173-81. PubMed ID: 15728439 [Abstract] [Full Text] [Related]
11. Effect of ultra-low-dose transdermal estradiol on breast density in postmenopausal women. Grady D, Vittinghoff E, Lin F, Hanes V, Ensrud K, Habel LA, Wallace R, Macer J, Cummings SR, Shepherd J. Menopause; 2007 Mar 10; 14(3 Pt 1):391-6. PubMed ID: 17224859 [Abstract] [Full Text] [Related]
13. A 3-day estrogen treatment improves prefrontal cortex-dependent cognitive function in postmenopausal women. Krug R, Born J, Rasch B. Psychoneuroendocrinology; 2006 Sep 10; 31(8):965-75. PubMed ID: 16831520 [Abstract] [Full Text] [Related]
14. A comparison of oral and transdermal short-term estrogen therapy in postmenopausal women with metabolic syndrome. Chu MC, Cosper P, Nakhuda GS, Lobo RA. Fertil Steril; 2006 Dec 10; 86(6):1669-75. PubMed ID: 17074346 [Abstract] [Full Text] [Related]
15. Hormone replacement therapy does not affect the 24-hour heart rate variability in postmenopausal women: results of a randomized, placebo-controlled trial with two regimens. Fernandes EO, Moraes RS, Ferlin EL, Wender MC, Ribeiro JP. Pacing Clin Electrophysiol; 2005 Jan 10; 28 Suppl 1():S172-7. PubMed ID: 15683490 [Abstract] [Full Text] [Related]
16. Estrogen + progestin therapy and cognition: a randomized placebo-controlled double-blind study. Alhola P, Tuomisto H, Saarinen R, Portin R, Kalleinen N, Polo-Kantola P. J Obstet Gynaecol Res; 2010 Aug 10; 36(4):796-802. PubMed ID: 20666948 [Abstract] [Full Text] [Related]
17. Effects of transdermal estrogen replacement therapy on plasma levels of nitric oxide and plasma lipids in postmenopausal women. Balci H, Altunyurt S, Acar B, Fadiloglu M, Kirkali G, Onvural B. Maturitas; 2005 Apr 11; 50(4):289-93. PubMed ID: 15780528 [Abstract] [Full Text] [Related]
18. Postmenopausal hormone therapy and cognition: effects of timing and treatment type. Khoo SK, O'Neill S, Byrne G, King R, Travers C, Tripcony L. Climacteric; 2010 Jun 11; 13(3):259-64. PubMed ID: 19886816 [Abstract] [Full Text] [Related]
19. Age-related cognitive decline in the menopause: effects of hormone replacement therapy on cognitive event-related potentials. Anderer P, Saletu B, Gruber D, Linzmayer L, Semlitsch HV, Saletu-Zyhlarz G, Brandstätter N, Metka M, Huber J. Maturitas; 2005 Jul 16; 51(3):254-69. PubMed ID: 15978969 [Abstract] [Full Text] [Related]
20. Hot flashes and estrogen therapy do not influence cognition in early menopausal women. LeBlanc ES, Neiss MB, Carello PE, Samuels MH, Janowsky JS. Menopause; 2007 Jul 16; 14(2):191-202. PubMed ID: 17194963 [Abstract] [Full Text] [Related] Page: [Next] [New Search]